• Mashup Score: 1

    Annals of Oncology Vol. 34 Issue 9 Annals of Oncology Vol. 34 Issue 9 Immuno-Oncology and Technology Vol. 19 Immuno-Oncology and Technology Vol. 19 Cancer Treatment Reviews Vol. 119 Cancer Treatment Reviews Vol. 118 Clinical Lymphoma, Myeloma and Leukemia Vol. 23 Issue 8 Clinical Lymphoma, Myeloma and Leukemia Vol. 23 Issue 8 Editor in Chief: Fabrice Andre Impact Factor: 51.769 Publishes research on innovative cancer treatments or translational work related to oncology and precision medicine. Focus on:

    Tweet Tweets with this article
    • Don’t miss the chance to meet the #ESMOOncologyJournals’ #EditorsinChief at #ESMO23, get your questions answered by them and learn about their vision. @Annals_Oncology @ESMO_Open @esmo_iotech @rdienstmann 🗓️ 22 Oct, 9:15-9:55 CEST, Networking Hub https://t.co/DvFVzlAtUX https://t.co/F2XgIJiRbU

  • Mashup Score: 1

    Annals of Oncology Vol. 34 Issue 9 Annals of Oncology Vol. 34 Issue 9 Immuno-Oncology and Technology Vol. 19 Immuno-Oncology and Technology Vol. 19 Cancer Treatment Reviews Vol. 119 Cancer Treatment Reviews Vol. 118 Clinical Lymphoma, Myeloma and Leukemia Vol. 23 Issue 8 Clinical Lymphoma, Myeloma and Leukemia Vol. 23 Issue 8 Editor in Chief: Fabrice Andre Impact Factor: 51.769 Publishes research on innovative cancer treatments or translational work related to oncology and precision medicine. Focus on:

    Tweet Tweets with this article
    • See this month’s highlights from the @myESMO portfolio. Featured content from @Annals_Oncology, @ESMO_Open, @ESMO_IOTECH, @TheBreastOnline, @LungCaJournal, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia https://t.co/oBh8FpIiSM https://t.co/ThluReEtQ8

  • Mashup Score: 3

    Annals of Oncology Vol. 34 Issue 8 Annals of Oncology Vol. 34 Issue 8 Immuno-Oncology and Technology Vol. 19 Immuno-Oncology and Technology Vol. 19 Cancer Treatment Reviews Vol. 118 Cancer Treatment Reviews Vol. 118 Editor in Chief: Fabrice Andre Impact Factor: 51.769 Publishes research on innovative cancer treatments or translational work related to oncology and precision medicine. Focus on: systemic anticancer therapy, randomized trials, top-level guidelines, and new fields currently emerging as key

    Tweet Tweets with this article
    • See this month’s highlights from the @myESMO portfolio. Featured content from @Annals_Oncology, @ESMO_Open, @ESMO_IOTECH, @TheBreastOnline, @LungCaJournal, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia https://t.co/ovxtLFAxcm https://t.co/WMi6F3UunQ